BREVEZE Trademark

Trademark Overview


On Tuesday, December 4, 2007, a trademark application was filed for BREVEZE with the United States Patent and Trademark Office. The USPTO has given the BREVEZE trademark a serial number of 77343672. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Thursday, May 8, 2008. This trademark is owned by Eli Lilly and Company. The BREVEZE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, anxiety, bone and skeletal diseases and disorders, blood diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, liver diseases and disorders, kidney diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and disorders, reproductive system diseases and disorders, sexual dysfunction, urological disorders, dyslipidemia, sleep disorders, migraines, metabolic diseases and disorders; antipsychotic agents; and antidepressants
breveze

General Information


Serial Number77343672
Word MarkBREVEZE
Filing DateTuesday, December 4, 2007
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateThursday, May 8, 2008
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 22, 2008

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, anxiety, bone and skeletal diseases and disorders, blood diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, liver diseases and disorders, kidney diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and disorders, reproductive system diseases and disorders, sexual dysfunction, urological disorders, dyslipidemia, sleep disorders, migraines, metabolic diseases and disorders; antipsychotic agents; and antidepressants

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateThursday, May 8, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Thursday, May 8, 2008ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
Thursday, May 8, 2008ABANDONMENT - AFTER PUBLICATION
Thursday, May 8, 2008REVIEW OF CORRESPONDENCE COMPLETE
Tuesday, April 22, 2008PUBLISHED FOR OPPOSITION
Wednesday, April 16, 2008TEAS EXPRESS ABANDONMENT RECEIVED
Wednesday, April 2, 2008NOTICE OF PUBLICATION
Tuesday, March 18, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, March 18, 2008ASSIGNED TO LIE
Saturday, March 1, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, March 1, 2008ASSIGNED TO EXAMINER
Friday, December 7, 2007NEW APPLICATION ENTERED IN TRAM